Return On Assets in % of CANNAPHARMARX, INC. from Q2 2012 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
CANNAPHARMARX, INC. quarterly/annual Return On Assets history and change rate from Q2 2012 to Q3 2025.
  • CANNAPHARMARX, INC. Return On Assets for the quarter ending 30 Sep 2025 was -64.9 %.
  • CANNAPHARMARX, INC. annual Return On Assets for 2023 was 53.7 %.
  • CANNAPHARMARX, INC. annual Return On Assets for 2022 was -152 %, a 6.36% decline from 2021.
  • CANNAPHARMARX, INC. annual Return On Assets for 2021 was -143 %, a 2.28% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

CANNAPHARMARX, INC. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -64.9 01 Jul 2025 30 Sep 2025
Q2 2025 -50 01 Apr 2025 30 Jun 2025
Q1 2024 -78.8 +65.2 +45.3% 01 Jan 2024 31 Mar 2024
Q4 2023 53.7 +205 01 Oct 2023 31 Dec 2023
Q3 2023 -142 +142 +50.1% 01 Jul 2023 30 Sep 2023
Q2 2023 -154 +99.8 +39.3% 01 Apr 2023 30 Jun 2023
Q1 2023 -144 +76.9 +34.8% 01 Jan 2023 31 Mar 2023
Q4 2022 -152 -9.06 -6.36% 01 Oct 2022 31 Dec 2022
Q3 2022 -284 -128 -82% 01 Jul 2022 30 Sep 2022
Q2 2022 -254 -117 -85.2% 01 Apr 2022 30 Jun 2022
Q1 2022 -221 -105 -90.8% 01 Jan 2022 31 Mar 2022
Q4 2021 -143 +3.32 +2.28% 01 Oct 2021 31 Dec 2021
Q3 2021 -156 -41.9 -36.7% 01 Jul 2021 30 Sep 2021
Q2 2021 -137 +6.4 +4.46% 01 Apr 2021 30 Jun 2021
Q1 2021 -116 +13.9 +10.7% 01 Jan 2021 31 Mar 2021
Q4 2020 -146 -44.3 -43.6% 01 Oct 2020 31 Dec 2020
Q3 2020 -114 -44.2 -63.1% 01 Jul 2020 30 Sep 2020
Q2 2020 -143 -107 -292% 01 Apr 2020 30 Jun 2020
Q1 2020 -130 -77.5 -148% 01 Jan 2020 31 Mar 2020
Q4 2019 -102 +12.2 +10.7% 01 Oct 2019 31 Dec 2019
Q3 2019 -70 +493 +87.6% 01 Jul 2019 30 Sep 2019
Q2 2019 -36.6 +52.8 +59.1% 01 Apr 2019 30 Jun 2019
Q1 2019 -52.2 01 Jan 2019 31 Mar 2019
Q4 2018 -114 01 Oct 2018 31 Dec 2018
Q3 2018 -563 -537 -2066% 01 Jul 2018 30 Sep 2018
Q2 2018 -89.4 -56.4 -171% 01 Apr 2018 30 Jun 2018
Q3 2017 -26 +47K +99.9% 01 Jul 2017 30 Sep 2017
Q2 2017 -33 +7.56K +99.6% 01 Apr 2017 30 Jun 2017
Q1 2017 -73.3 +2.9K +97.5% 01 Jan 2017 31 Mar 2017
Q4 2016 -236 +1.32K +84.8% 01 Oct 2016 31 Dec 2016
Q3 2016 -47K -46.1K -5132% 01 Jul 2016 30 Sep 2016
Q2 2016 -7.59K -7.04K -1274% 01 Apr 2016 30 Jun 2016
Q1 2016 -2.98K -2.69K -938% 01 Jan 2016 31 Mar 2016
Q4 2015 -1.55K 01 Oct 2015 31 Dec 2015
Q3 2015 -899 01 Jul 2015 30 Sep 2015
Q2 2015 -552 01 Apr 2015 30 Jun 2015
Q1 2015 -287 01 Jan 2015 31 Mar 2015
Q2 2013 -365K +148K +28.9% 01 Apr 2013 30 Jun 2013
Q1 2013 -340K 01 Jan 2013 31 Mar 2013
Q4 2012 -392K 01 Oct 2012 31 Dec 2012
Q3 2012 -397K 01 Jul 2012 30 Sep 2012
Q2 2012 -513K 01 Apr 2012 30 Jun 2012

CANNAPHARMARX, INC. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2023 53.7 +205 01 Jan 2023 31 Dec 2023
2022 -152 -9.06 -6.36% 01 Jan 2022 31 Dec 2022
2021 -143 +3.32 +2.28% 01 Jan 2021 31 Dec 2021
2020 -146 -44.3 -43.6% 01 Jan 2020 31 Dec 2020
2019 -102 +12.2 +10.7% 01 Jan 2019 31 Dec 2019
2018 -114 01 Jan 2018 31 Dec 2018
2016 -236 +1.32K +84.8% 01 Jan 2016 31 Dec 2016
2015 -1.55K 01 Jan 2015 31 Dec 2015
2012 -392K 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.